RPS6KB1 and neoplasm: Rapamycin was initially considered as a potent inhibitor of translation and thus, e.g., inhibiting tumor growth through inhibition of MTORC1 complex and downstream inhibition of 4E-BP1 and P70S6K signaling (31).